Ann D. Thor - Concepedia

Author

Ann D. Thor

University of Colorado Anschutz Medical Campus ORCID

Also Known As

A D Thor, A De widerspach thor, A Thor, A. D. THOR, A. D. Thor, A. Thor, A.D. Thor, ANN THOR, Ann D Thor, Ann D. Thor

298

Publications

22.8K

Citations

H-Index

129

Concepts

All Affiliations

University of Colorado Anschutz Medical Campus University of Colorado Denver Massachusetts General Hospital University of Oklahoma Health Sciences Center University of California, San Francisco

About

Ann D. Thor is an author at University of Colorado Anschutz Medical Campus specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	81	9K
2	Health Sciences	8	8	1.1K
3	Natural Sciences	2	2	119
4	Engineering	1	1	38
5	Public Health	1	1	11

Ann D. Thor

161

Publications

20.8K

Citations

H-Index

Page 1

	Year	Citations
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer S. Eva Singletary, Craig Allred, Pandora Ashley, Journal of Clinical Oncology	2002	1.2K
c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer Hyman B. Muss, Ann D. Thor, Donald A. Berry, New England Journal of Medicine	1994	968
Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial Cells Zhiqiang Zou, Anthony Anisowicz, Mary J.C. Hendrix, Science Breast OncologyPathologyMaspin GeneCancer BiologyTumor Biology	1994	909
Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers Ann D. Thor, Dan H. Moore, S M Edgerton, JNCI Journal of the National Cancer Institute	1992	733
erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer Ann D. Thor, Donald A. Berry, Daniel R. Budman, JNCI Journal of the National Cancer Institute	1998	615
Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100 Bryan P. Schneider, Milan Radovich, George W. Sledge, Journal of Clinical Oncology	2008	607
HER2 and Response to Paclitaxel in Node-Positive Breast Cancer Daniel F. Hayes, Ann D. Thor, Lynn G. Dressler, New England Journal of Medicine	2007	604
Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas Guoren Deng, You Lü, G Zlotnikov, Science Breast OncologyCancer PathologyGeneticsFrequent AberrationPathology	1996	587
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Olli Kallioniemi, Anne Kallioniemi, Wayne Kurisu, Proceedings of the National Academy of Sciences Breast OncologyCytogeneticsGeneticsErbb2 Copy NumberMolecular Biology	1992	552
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro Irina Alimova, Bolin Liu, Zeying Fan, Cell Cycle	2009	518

Page 1